| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/23/2011 | CN101981056A Composition comprising antibody that binds to domain II of HER2 and acidic variants thereof |
| 02/23/2011 | CN101981055A Anti-CD79B antibodies and immunoconjugates and methods of use |
| 02/23/2011 | CN101981054A Novel antibodies inhibiting c-MET dimerization, and uses thereof |
| 02/23/2011 | CN101981053A Pegylated Abeta FAB |
| 02/23/2011 | CN101981052A Compositions, methods and kits |
| 02/23/2011 | CN101980017A Anti-TNF antibodies, compositions, methods and uses |
| 02/23/2011 | CN101979650A Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy |
| 02/23/2011 | CN101979512A Anti-porcine reproductive and respiratory syndrome virus monoclonal antibody and application |
| 02/23/2011 | CN101979511A Heavy metal zinc-resistant monoclonal antibody |
| 02/23/2011 | CN101979412A IL-18 binding proteins |
| 02/23/2011 | CN101979404A Conserved neutralizing epitope mimic peptide of H5 subtype avian influenza viruses and use thereof |
| 02/23/2011 | CN101058608B Human anti-Abeta(1-32) amyloid antibody, purifying method and use thereof |
| 02/22/2011 | US7893246 Sirna capable of inhibiting the expression of an oncogene involved in cervical cancer |
| 02/22/2011 | US7893220 Busulfan immunoassay |
| 02/22/2011 | US7893219 Protective anti-glucan antibodies with preference for β-1,3- glucans |
| 02/22/2011 | US7893218 Antibodies that specifically bind SOST peptides |
| 02/22/2011 | US7893217 Isolated human antibodies that bind epitopes on RG1 |
| 02/22/2011 | US7893216 Anti-human trail receptor DR5 monoclonal antibody (AD5-10), method thereof and use of the same |
| 02/22/2011 | US7893215 Agonist antibodies to IL-23 receptor |
| 02/22/2011 | US7893214 Humanized antibodies that recognize beta amyloid peptide |
| 02/22/2011 | US7893213 Antibodies to activin receptor |
| 02/22/2011 | US7893212 S-nitroso group-containing albumin, method for production, and anticancer agent |
| 02/22/2011 | US7893209 Slo2, novel potassium channel proteins from human brain |
| 02/22/2011 | US7893205 Hemopoietin receptor protein, NR12 |
| 02/22/2011 | US7893204 Attractin/mahogany-like polypeptides |
| 02/22/2011 | US7893201 Hemopoietin receptor protein, NR12 |
| 02/22/2011 | US7893200 Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases |
| 02/22/2011 | US7893031 Neuronal differentiation inhibitor peptide and use thereof |
| 02/22/2011 | US7892818 Method and kit for the determination of cellular activation profiles |
| 02/22/2011 | US7892803 Gene and uses therefor to modify pasture qualities of crops |
| 02/22/2011 | US7892786 Methods for expression and purification of immunotoxins |
| 02/22/2011 | US7892773 Expression vector comprising nucleotide sequences coding homeobox transcriptional regulator gene for identifying modulators for treatment and prevention of cell proliferative disorders of urogenital system |
| 02/22/2011 | US7892770 Monoclonal antibody which binds cMet (HGFR) in formalin-fixed and paraffin-embedded tissues and related methods |
| 02/22/2011 | US7892754 Hepatitis B virus pre-S1 derived synthetic polypeptides and uses thereof |
| 02/22/2011 | US7892751 Using antiphospholipid autoantibody expression profile as evaluative tool in screening for alzheimer's disease |
| 02/22/2011 | US7892749 Methods for differentiating and monitoring parathyroid and bone status related diseases |
| 02/22/2011 | US7892563 Methods for treatment of severe acute respiratory syndrome (SARS) |
| 02/22/2011 | US7892554 Using immunoglobulin fusion to deliver effector cells; tissue targeted therapy; antitumor agents |
| 02/22/2011 | US7892549 Treatment with anti-ErbB2 antibodies |
| 02/22/2011 | US7892548 121P1F1: a tissue specific protein highly expressed in various cancers |
| 02/22/2011 | US7892547 Methods and compositions for administering therapeutic and diagnostic agents |
| 02/22/2011 | US7892546 Anti-CXCR4 antibodies |
| 02/22/2011 | US7892545 Humanized antibodies that sequester amyloid beta peptide |
| 02/22/2011 | US7892544 Humanized anti-beta-amyloid antibody |
| 02/22/2011 | US7892543 Chimeric antibodies; lymphocytes; genetic engineering; for treatment of myeloma |
| 02/22/2011 | US7892542 Human anti-idiotypic antibody fragments that mimic HER-2/neu |
| 02/22/2011 | US7892539 Modulation of an innate immune response by altering TRIAL-R signaling |
| 02/22/2011 | US7892538 Monovalent ligand of the FcαRI receptor as an anti-inflammatory agent |
| 02/22/2011 | CA2554195C Peptide originating in epidermal growth factor receptor (egfr) |
| 02/22/2011 | CA2441566C Blood cell production via activation of the hemoglobin scavenger receptor |
| 02/22/2011 | CA2435503C Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy |
| 02/22/2011 | CA2410193C Neuronal serine-threonine protein kinase |
| 02/22/2011 | CA2409208C Method for examining wt1-related disease |
| 02/22/2011 | CA2329772C Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens |
| 02/22/2011 | CA2253875C Early detection of lysosomal storage disorders |
| 02/22/2011 | CA2143491C A novel peptide related to human programmed cell death and dna encoding it |
| 02/17/2011 | WO2011020079A1 Antibodies against human respiratory syncytial virus (rsv) and methods of use |
| 02/17/2011 | WO2011019932A2 Compositions and methods for the therapy and diagnosis of influenza |
| 02/17/2011 | WO2011019679A1 Ccr2 inhibitors for treating conditions of the eye |
| 02/17/2011 | WO2011019622A1 Cell culture methods to make antibodies with enhanced adcc function |
| 02/17/2011 | WO2011019620A1 Antibodies with enhanced adcc function |
| 02/17/2011 | WO2011019065A1 Tumor angiogenesis inhibitor |
| 02/17/2011 | WO2011018779A1 Modified helicobacter protein |
| 02/17/2011 | WO2011018421A1 Novel screening strategies for the identification of binders |
| 02/17/2011 | WO2011018225A1 Combination therapy of an afucosylated cd20 antibody with fludarabine and/or mitoxantrone |
| 02/17/2011 | WO2011018224A1 Combination therapy of an afucosylated cd20 antibody with bendamustine |
| 02/17/2011 | WO2011018208A1 Human monoclonal antibody against s. aureus derived alpha-toxin and its use in treating or preventing abscess formation |
| 02/17/2011 | WO2011017791A1 Monoclonal antibodies against the pbp2-a protein and homologous sequences for the treatment of infections by and immunodiagnostics of bacteria of the firmicutes phylum |
| 02/17/2011 | WO2011017770A1 Method for detection of endometriosis |
| 02/17/2011 | WO2010104747A3 Antigen presenting cell targeted vaccines |
| 02/17/2011 | WO2010092176A3 Nontypable haemophilus influenzae antigens |
| 02/17/2011 | WO2010046289A3 Blockers of light, ltalpha1beta2 and ltalpha2beta1 or their receptor ltbetar for the prevention and treatment of chronic hepatitis and other liver diseases |
| 02/17/2011 | WO2009155670A8 Pharmaceutical compositions of antibodies for diseases caused by viruses |
| 02/17/2011 | WO2005072055A9 Novel brain natriuretic peptide variants and methods of use thereof |
| 02/17/2011 | US20110040249 Human Anti-IL-23 Antibodies, Compositions, Methods and Uses |
| 02/17/2011 | US20110040076 Human Anti-NGF Neutralizing Antibodies as Selective NGF Pathway Inhibitors |
| 02/17/2011 | US20110040075 Antibody purification by protein a and ion exchange chromatography |
| 02/17/2011 | US20110040074 Production methods |
| 02/17/2011 | US20110039783 Peptide having hypotensive activity |
| 02/17/2011 | US20110039729 Glycosylated protein expression in prokaryotes |
| 02/17/2011 | US20110039353 Method for direct detection of ischemia-modified albumin using a partner for binding to an aldehyde derivative resulting from the peroxidation of lipids in bound form |
| 02/17/2011 | US20110039331 Tag peptide and use thereof |
| 02/17/2011 | US20110039279 Methods and compositions for diagnosing breast cancer |
| 02/17/2011 | US20110038935 Antibodies against influenza virus and methods of use thereof |
| 02/17/2011 | US20110038894 Immunogenic Peptides of Tumor Associated Antigen L6 and Uses Thereof in Cancer Therapy |
| 02/17/2011 | US20110038883 He4 monoclonal antibodies and methods for their use |
| 02/17/2011 | US20110038879 Immunogenic and therapeutic compositions for streptococcus pyogenes |
| 02/17/2011 | US20110038878 Antibodies to il-17a |
| 02/17/2011 | US20110038877 Interleukin-6 antagonists |
| 02/17/2011 | US20110038875 Hematopoietic cells expressing the protein susd3 and ligands for the protein susd3 |
| 02/17/2011 | US20110038874 Anti-vegfr monoclonal antibody, method of making and uses thereof |
| 02/17/2011 | US20110038870 Compositions and methods to enhance the immune system |
| 02/17/2011 | US20110038869 Monoclonal antibodies against cd32b |
| 02/17/2011 | US20110038868 Il-17 homologous polypeptides and therapeutic uses thereof |
| 02/17/2011 | US20110038867 Remedies for pemphigus containing anti fas ligand antibodies |
| 02/17/2011 | US20110038864 Antibodies Against Cancer Antigen TMEFF2 and Uses Thereof |
| 02/17/2011 | US20110038863 Methods and compositions for improving recombinant protein production |
| 02/17/2011 | US20110038861 Methods of Treating Alzheimer's Disease Using Antibodies Directed Against Amyloid Beta Peptide and Compositions Thereof |
| 02/17/2011 | US20110038860 Methods for inhibition of polyclonal b cell activation and immunoglobulin class switching to pathogenic autoantibodies by blocking cd1-mediated interactions |
| 02/17/2011 | US20110038854 Strategy for homo- or hetero-dimerization of various proteins in solution and in cell |